Wave Life Sciences (WVE) Free Cash Flow Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 31.42% |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | -39.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.34% |
| Dec 31, 2025 | -0.13% |
| Sep 30, 2025 | -19.83% |
| Jun 30, 2025 | -16.47% |
| Mar 31, 2025 | -16.40% |
| Dec 31, 2024 | -83.76% |
| Sep 30, 2024 | -18.33% |
| Jun 30, 2024 | -41.37% |
| Mar 31, 2024 | 8.70% |
| Dec 31, 2023 | -1.66% |
| Sep 30, 2023 | -19.64% |
| Jun 30, 2023 | 0.84% |
| Mar 31, 2023 | 72.91% |
| Dec 31, 2022 | 18.69% |
| Sep 30, 2022 | 16.07% |
| Jun 30, 2022 | 5.31% |
| Mar 31, 2022 | 7.65% |
| Dec 31, 2021 | 42.09% |
| Sep 30, 2021 | 4.43% |
| Jun 30, 2021 | -28.87% |
| Mar 31, 2021 | -9.81% |
| Dec 31, 2020 | 7.37% |
| Sep 30, 2020 | -9.00% |
| Jun 30, 2020 | -13.31% |
| Mar 31, 2020 | -9.57% |
| Dec 31, 2019 | -53.46% |
| Sep 30, 2019 | -54.96% |
| Jun 30, 2019 | -226.94% |
| Mar 31, 2019 | -90.85% |
| Dec 31, 2018 | -68.10% |
| Sep 30, 2018 | -112.91% |
| Jun 30, 2018 | 246.58% |
| Mar 31, 2018 | -173.83% |
| Dec 31, 2017 | -290.98% |